Researcher
Karin Thevissen
- Disciplines:Infectious diseases, Mycology
Affiliations
- Microbial and Plant Genetics (CMPG) (Division)
Member
From1 Aug 2020 → Today - Centre of Microbial and Plant Genetics (Division)
Member
From1 Aug 2005 → 31 Jul 2020
Projects
1 - 10 of 27
- PHGDH-ASM: Phosphoglycerate dehydrogenase (PHGDH) activators as novel antiseizure medications (ASM) with dual mode of actionFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Targeting intestinal macrophages as new treatment for Inflammatory Bowel Disease. IBD-MAC.From1 Oct 2021 → 30 Sep 2023Funding: IOF - technology validation in lab
- Sustainable development of a safe & biobased Antimicrobial, Antifungal and Antiviral nanoCOATing platformFrom1 Jun 2021 → 31 May 2023Funding: BOF - various
- Dual-band fibered confocal fluorescence microscope for the intravital interrogation of deep tissues and organs in real time and with cellular resolutionFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Repurposing of existing chemicals as inducers of plant resistance for a more sustainable agriculture.From27 Aug 2019 → 27 Aug 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- ‘Bisceps’ Biofilm susceptibility sensors for in situ biofilm monitoring.From1 Jan 2019 → 31 Dec 2022Funding: FWO Strategic Basic Research (SBO)
- Preclinical characterization of miconazole potentiators as novel treatment of biofilm-related infections and epilepsyFrom1 Jan 2018 → 29 Sep 2021Funding: BOF - doctoral mandates
- In vivo validation of the resistance-proof activity of 2-aminoimidazole based anti-biofilm coatings for medical implantsFrom1 Oct 2017 → 30 Sep 2019Funding: IOF - Industrial Research Fund
- iDAIpps: Indwelling device associated infections: pathology and preventive solutions.From15 Jul 2017 → 14 Jul 2019Funding: BOF - Bilateral scientific cooperation
- Metabolic rewiring in cancer: Pharmacological targeting of serine/glycine synthesis addicted cancersFrom24 May 2017 → 15 Dec 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
21 - 30 of 146
- Combination Therapy to Treat Fungal Biofilm-Based Infections(2020)
Authors: Bruno Cammue, Karin Thevissen
- Combination of Miconazole and Domiphen Bromide Is Fungicidal against Biofilms of Resistant Candida spp.(2020)
Authors: Bruno Cammue, Karin Thevissen
- Fluorescence-free First Hyperpolarizability Values of Fluorescent Proteins and Channel Rhodopsins(2020)
Authors: Yovan de Coene, Chris Van den Haute, Karin Thevissen, Veerle Baekelandt, Carmen Bartic, Johan Hofkens, Koen Clays
Pages: 1 - 8 - The antifungal plant defensin HsAFP1 induces autophagy, vacuolar dysfunction and cell cycle impairment in yeast(2020)
Authors: Caroline Struyfs, Bruno Cammue, Karin Thevissen
- Establishing a Unified COVID-19 “Immunome”: Integrating Coronavirus Pathogenesis and Host Immunopathology(2020)
Authors: Els Wauters, Karin Thevissen, Carine Wouters, Francesca Bosisio, Frederik De Smet, Jan Gunst, Stephanie Humblet-Baron, Diether Lambrechts, Adrian Liston, Patrick Matthys, et al.
Pages: 1642 - 1642 - International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe (vol 24, 84, 2020)(2020)
Authors: Karin Thevissen, Cato Jacobs, Michelle Holtappels, Mitsuru Toda, Paul Verweij, Joost Wauters
- International survey on influenza-associated pulmonary aspergillosis (IAPA) in intensive care units: responses suggest low awareness and potential underdiagnosis outside Europe(2020)
Authors: Karin Thevissen, Joost Wauters
- Tuning the surface interactions between single cells and an OSTE+ microwell array for enhanced optical tweezers manipulation(2019)
Authors: Jolien Breukers, Karin Thevissen, Bruno Cammue, Bob Puers, Jeroen Lammertyn
- Integrated Microwell Array Technologies for Single Cell Analysis(2019)
Authors: Jolien Breukers, Caroline Struyfs, Sara Horta, Karin Thevissen, Karen Vanhoorelbeke, Bruno Cammue, Jeroen Lammertyn
Number of pages: 32 - Substrate -Specificity of Candida rugosa Lipase and Its Industrial Application(2019)
Authors: Karin Thevissen, Bert Lagrain, Michiel Dusselier, Bruno Cammue, Bert Sels
Pages: 15828 - 15844
Patents
1 - 10 of 10
- Idebenone in the treatment of drug resistant epilepsy (Inventor)
- Compositions against candida infections (Inventor)
- Treatment of epilepsy (Inventor)
- Compositions against candida infections (Inventor)
- Pharmacological targeting of de novo serine/glycine synthesis (Inventor)
- Compositions against candida infections (Inventor)
- Compositions and methods for treating biofilms (Inventor)
- Agents for increased resistance against oxidative stress conditions (Inventor)
- ANTIFUNGAL COMPOUNDS (Inventor)
- USE OF A MEDICAMENT CONSISTING OF ANTIBIOTIC, ANTIFUNGAL E.G. MICONAZOLE, ANTIVIRAL, ANTIINFLAMMATORY, ANALGESIC AND/OR ANTIHYPERTENSIVE IN THE TREATMENT OR IN THE PREVENTION IN PATIENT OF A MICROBIAL INFECTION IN THE FORM OF A BIOFILM (Inventor)